Aclaris Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Wayne, PA
ACRS chart
What traders are saying about $ACRS
Latest postsAclaris Therapeutics, Inc. news
- Aclaris Reports ATI-052 Phase 1b Results in Eczema and Asthma
grafa.com ·
- Aclaris Therapeutics Reports Positive Phase 1b ATI-052 Trial Results, Prices $50 Million Offering
Yahoo Finance ·
- Aclaris Reports Positive Asthma, Eczema Drug Trial Results — So, Why Is ACRS Stock Down Nearly 8%?
stocktwits.com ·
- Aclaris Therapeutics Prices $50 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Quiver Quantitative ·
- Aclaris Therapeutics Announces Pricing of $50.0 Million Offering of Common Stock and Pre-Funded Warrants
Yahoo Finance ·
- Form 8K Aclaris Therapeutics Inc For: 27 October By Investing.com
Investing.com Nigeria ·
- Aclaris Therapeutics Announces Positive Phase 1b Proof-of-Concept Primary Analysis Results for its Anti-TSLP/IL-4Rα Bispecific ATI-052 in Atopic Dermatitis (AD) and Asthma
Yahoo Finance ·
- Aclaris Therapeutics Announces Positive Phase 1b
GlobeNewswire ·
- Aclaris Therapeutics, Inc. Estimates – SWB:8AT
TradingView ·
- Are Medical Stocks Lagging Aclaris Therapeutics (ACRS) This Year?
Yahoo Finance ·
- Aclaris (ACRS) Soars 6.0%: Is Further Upside Left in the Stock?
Yahoo Finance ·
- Aclaris Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
Yahoo Finance ·
Aclaris Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $7.8M | $18.7M | $31.2M | $29.8M |
| Net income | -$64.9M | -$132.1M | -$88.5M | -$86.9M |
| Diluted EPS | $-0.53 | $-1.71 | $-1.27 | $-1.33 |
| Total assets (year end) | $160.5M | $220.3M | $197.4M | $254.6M |
| Cash and equivalents (year end) | $20.0M | $24.6M | $39.9M | $45.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Aclaris Therapeutics, Inc.
- Ticker
- ACRS (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Wayne, PA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1557746
Frequently asked questions
What exchange is Aclaris Therapeutics, Inc. listed on?
Aclaris Therapeutics, Inc. trades on the Nasdaq under the ticker symbol ACRS.
What industry is Aclaris Therapeutics, Inc. in?
Aclaris Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Aclaris Therapeutics, Inc. headquartered?
Aclaris Therapeutics, Inc.'s business address on file with the SEC is in Wayne, PA.
When does Aclaris Therapeutics, Inc.'s fiscal year end?
Aclaris Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Aclaris Therapeutics, Inc. report?
Aclaris Therapeutics, Inc. reported $7.8M in revenue for calendar year 2025, according to its SEC filings.